Kaya Holdings (KAYS) FCF Margin Growth (5y) (2019 - 2025)

Kaya Holdings (KAYS) FCF Margin Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Kaya Holdings - - 5,370.00

Historic Data

Download Data
DateValue
Sep 30, 2025 -121,917.00
Jun 30, 2025 -202,842.00
Mar 31, 2025 -255,190.00
Dec 31, 2024 144,663.00
Sep 30, 2024 -106,222.00
Mar 31, 2024 -33,470.00
Dec 31, 2023 -85,636.00
Sep 30, 2023 -11,912.00
Jun 30, 2023 -60,109.00
Mar 31, 2023 -45,712.00
Dec 31, 2022 1,029.00
Sep 30, 2022 18,641.00
Jun 30, 2022 8,658.00
Dec 31, 2021 1,233.00
Sep 30, 2021 -172.00
Jun 30, 2021 -8,854.00
Mar 31, 2021 163.00
Dec 31, 2020 11,519.00
Sep 30, 2020 94,318.00
Jun 30, 2020 48,508.00